Skip to main content
. Author manuscript; available in PMC: 2023 Mar 16.
Published in final edited form as: Br J Clin Pharmacol. 2022 Nov 8;89(3):1176–1186. doi: 10.1111/bcp.15569

Table 2. Multivariable Linear Mixed Effects Regression Analysis of Pulse Rate and Blood Pressure in Malaria Following Treatment with Amodiaquine.

    Pulse Rate (beats/minute) Systolic Blood Pressure – Supine (mmHg) Diastolic Blood Pressure – Erect (mmHg)
Univariable Analyses Multivariable Analyses Univariable Analyses Multivariable Analyses Univariable Analyses Multivariable Analyses
Number of Observations Crude Estimate (95% CI) p value Adjusted Estimate (95% CI) p value Crude Estimate (95% CI) p value Adjusted Estimate (95% CI) p value Crude Estimate (95% CI) p value Adjusted Estimate (95% CI) p value
Total plasma concentration of amodiaquine and desethylamodiaquine, per 750* nmol/litre increase 362 -19.51 (-23.10 to -15.92) <0.0001 -14.57 (-18.22 to -10.92) <0.0001 -18.09 (-20.99 to -15.20) <0.0001 -12.43 (-15.95 to -8.92) <0.0001 -10.64 (-13.03 to -8.25) <0.0001 -10.26 (-13.11 to -7.42) <0.0001
Body temperature change, per 1°C increase 362 9.72 (8.32 to 11.12) <0.0001 5.65 (3.74 to 7.56) <0.0001 4.46 (3.14 to 5.79) <0.0001 2.97 (1.94 to 4.00) <0.0001
Malaria 362
  Yes (days 0-2) 106 -3.21 (-5.54 to -0.90) 0.0066 2.98 (0.50 to 5.46) 0.0186 -9.41 (-11.52 to -7.30) <0.0001 -4.53 (-6.93 to -2.13) 0.0002 -1.13 (-2.84 to 0.58) 0.1958 2.91 (0.97 to 4.85) 0.0034
  No (days 3-28) 256 Reference Reference Reference Reference Reference Reference
Sex 362
  Female 193 Reference Reference Reference Reference
  Male 169 3.06 (-4.81 to 10.93) 0.4388 4.12 (-4.17 to 12.41) 0.3232 2.52 (-3.74 to 8.78) 0.4231 4.14 (-0.80 to 9.08) 0.0985
*

Mean maximum total plasma drug concentration (rounded) after a 3-day course of amodiaquine from pharmacokinetic analysis of same study